News EVERSANA joins with Veeva in push to 'pharmatise AI' EVERSANA has joined the growing roster of companies partnering with Veeva on the development of GenAI applications for the life sciences industry.
News Industry alarm as FDA's CBER head Peter Marks resigns Industry organisations are alarmed by the resignation of senior FDA official Peter Marks, citing "misinformation and lies" by HHS Secretary Kennedy.
News Lilly adds Alzheimer's to its DTC platform LillyDirect Eli Lilly's DTC platform LillyDirect has been expanded to include in-person and telehealth services for people in the US living with Alzheimer's.
News First gene-edited pig liver transplant 'worked for 10 days' In a xenotransplant milestone, scientists have carried out the first transplant of a genetically modified pig liver into a brain-dead human patient.
News BIO rings alarm bells over Trump's pharma tariffs US tariffs on goods coming from Europe, China, and Canada could have a major impact on the biopharma industry and medicines access, says BIO.
News UK sets aside £2m for digitally-enhanced dementia tests The UK is providing £2m in funding to allow digital assessment to be added to a highly-anticipated trial of blood tests for diagnosing dementia.
Sales & Marketing Biotech is back, with Craig Ackerman In Philadelphia this month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.